Opexa Therapeutics (OPXA) Reports Q3 Loss Per Share of $0.42

November 10, 2015 4:17 PM EST

Opexa Therapeutics (NASDAQ: OPXA) reported Q3 EPS of ($0.42), versus ($1.11) reported last year. Revenue for the quarter came in at $726 thousand, versus $307 thousand reported last year.

For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings